Victory Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-17,330
| Closed | -$899K | – | 2622 |
|
|
2022
Q3 | $899K | Sell |
17,330
-1,793
| -9% | -$93K | ﹤0.01% | 1782 |
|
|
2022
Q2 | $904K | Buy |
19,123
+3,009
| +19% | +$142K | ﹤0.01% | 1797 |
|
|
2022
Q1 | $1.04M | Buy |
16,114
+8,657
| +116% | +$558K | ﹤0.01% | 1794 |
|
|
2021
Q4 | $558K | Buy |
+7,457
| New | +$558K | ﹤0.01% | 2095 |
|
|
2021
Q2 | – | Sell |
-5,101
| Closed | -$252K | – | 2771 |
|
|
2021
Q1 | $252K | Sell |
5,101
-1,593
| -24% | -$78.7K | ﹤0.01% | 2458 |
|
|
2020
Q4 | $282K | Buy |
6,694
+677
| +11% | +$28.5K | ﹤0.01% | 2299 |
|
|
2020
Q3 | $275K | Sell |
6,017
-10,043
| -63% | -$459K | ﹤0.01% | 2187 |
|
|
2020
Q2 | $806K | Buy |
16,060
+8,038
| +100% | +$403K | ﹤0.01% | 1822 |
|
|
2020
Q1 | $412K | Buy |
8,022
+3,026
| +61% | +$155K | ﹤0.01% | 2149 |
|
|
2019
Q4 | $309K | Buy |
4,996
+634
| +15% | +$39.2K | ﹤0.01% | 2196 |
|
|
2019
Q3 | $262K | Buy |
4,362
+3,569
| +450% | +$214K | ﹤0.01% | 2124 |
|
|
2019
Q2 | $67K | Sell |
793
-1,377
| -63% | -$116K | ﹤0.01% | 1695 |
|
|
2019
Q1 | $207K | Sell |
2,170
-809
| -27% | -$77.2K | ﹤0.01% | 1558 |
|
|
2018
Q4 | $211K | Buy |
2,979
+116
| +4% | +$8.22K | ﹤0.01% | 1545 |
|
|
2018
Q3 | $245K | Buy |
+2,863
| New | +$245K | ﹤0.01% | 1558 |
|